Variants of the BTB/POZ domain-containing protein 9 gene (BTBD9) (rs4714156, rs9357271, and rs9296249) and the serotonin 5-HT-2C receptor gene (HTR2C) (rs518147 and rs3813929) were reported to be associated with Tourette syndrome (TS) in White population recently. To examine the association between variants of the BTBD9 and the HTR2C genes and patients with TS among a Chinese Han population, 110 patients with TS and 440 sex-matched, age-matched, and ethnicity-matched healthy controls underwent sequencing and association analysis. There was a statistically significant association between the variant rs9296249 of the BTBD9 gene and the TS phenotype. However, no statistically significant associations were found between the other four variants (rs4714156, rs9357271, rs518147, and rs3813929) and the TS phenotype (P > 0.05). 
Introduction
Tourette syndrome (TS, MIM 137580), a neurological disorder manifested particularly by motor and vocal tics, and associated with a variety of behavioral abnormalities, has a prevalence ranging from 0.43 to 4.2% (Jankovic, 2001; Jin et al., 2004) . Although environmental causes have been proposed to play a role, the genetic factor is believed to contribute to its onset. At least seven chromosomal abnormalities have been reported in patients with TS phenotypes, and several TS gene loci have been identified by cytogenetic and linkage analysis. Although several genes, including the inner mitochondrial membrane peptidase 2-like gene (IMMP2L), the contactin-associated protein 2 gene (CNTNAP2), the Slit and Trk-like 1 gene (SLITRK1), and the L-histidine decarboxylase gene (HDC), were proposed as causative factors for monogenetic TS (Petek et al., 2001; Verkerk et al., 2003; Abelson et al., 2005; Ercan-Sencicek et al., 2010) , subsequent studies showed that some of these results could not be duplicated or were difficult to confirm, supporting the genetic basis of most cases of TS presenting as a risk susceptibility (Deng et al., 2006; Belloso et al., 2007; Petek et al., 2007 The BTBD9 variants may reduce the iron content in the ventral midbrain (Jones et al., 2003) , which is consistent with lower ferritin and serum iron in patients with TS (Gorman et al., 2006) , whereas the HTR2C variants may affect the dopamine release in the striatum and lead to decreased dopamine availability in the basal ganglia, thereby inducing tics in patients (Dehning et al., 2010) . To determine whether genetic variants in these two genes play a role in the etiology of Chinese Han patients with TS, we analyzed the reported five positive variants (rs4714156, rs9357271, and rs9296249 of the BTBD9 gene, rs518147 and rs3813929 of the HTR2C gene) in patients with TS from China.
Methods

Study participants
One hundred and ten unrelated Chinese Han patients with TS from China (mean age 10.7±5.6 years; mean age at onset: 8.0±4.6 years, male/female: 88/22) and 440 sexmatched, age-matched, and ethnicity-matched normal controls (mean age 10.8±5.8 years, male/female: 352/88) were enrolled in this study. The diagnosis of TS was made according to the DSM-IV-TR criteria for TS (American Psychiatric Association, 2000) . The patients were evaluated using the Yale Global Tic Severity Scale and the score was 48.2±11.4 (Leckman et al., 1989) . Forty-five percent (49/110) of these patients also had attentiondeficit disorder or/and hyperactivity, and 15% patients (16/110) had obsessive-compulsive disorder. All individuals were screened using the Chinese Wechsler Intelligence Scale for Children and mental retardation was ruled out. All of the patients were found to be negative for the histidine decarboxylase gene (HDC) mutations (Lei et al., 2012) . A detailed family history was obtained from each individual and 29 patients were found to have a family history of TS. This study was approved by the Institutional Review Board of the Third Xiangya Hospital, and all participating individuals or their guardians signed their informed consent.
Genetic analysis
Genomic DNA was isolated from whole blood using the standard phenol/chloroform method. PCR products were generated with a 50 ng DNA template in 2.5 ml 10 Â PCR buffer, 2.0 ml of 2.5 mmol/l each dNTP, 1.5 ml of 25 mmol/l MgCl 2 , 1 ml of 10 mol/l each primer (primer sequences available upon request), and 1 U Taq polymerase in a total volume of 25 ml. PCR amplification of the rs4714156, rs9296249, and rs9357271 in the BTBD9 gene, and the rs518147 and rs3813929 in the HTR2C gene was carried out using a GeneAmp 9700 PCR thermal cycler (Applied Biosystems, Foster City, California, USA) for 35 cycles at 951C for 40 s, 571C for 40 s, and 721C for 40 s, and elongation at 721C for 5 min. PCR products were analyzed and sequenced on a 310 Genetic Analyzer (Applied Biosystems, Foster City, California, USA) (Guo et al., 2009) . Genetic analyses were carried out blinded to case-control status.
Statistical analysis
A goodness-of-fit w 2 -test was used to determine whether the variants were in Hardy-Weinberg equilibrium. Pearson's w 2 -tests were used to test for the significance of differences in the allele frequencies. P values lower than 0.05 were considered significant. Haplotype analysis was carried out using SHEsis online software (Bio-X Life Science Research Center, Shanghai Jiao Tong University, Shanghai, China) (Li et al., 2009 ) and statistical analysis was carried out using the SPSS software (SPSS Inc., Chicago, Illinois, USA) (version 10 for Windows) (Deng et al., 2010) .
Results
Loci information and allele frequencies are presented in Table 1 . The genotype frequencies of all tested single nucleotide polymorphisms were in accordance with the Hardy-Weinberg equilibrium in the controls and the patients. A statistically significant association was observed between patients with TS compared with normal controls for variant rs9296249 of the BTBD9 gene (P = 0.010, w 2 = 6.603 for total TS vs. controls; w 2 = 6.596, P = 0.010 for male TS vs. controls after stratifying by sex), consistent with the previous report (Rivière et al., 2009). There were no significant associations between the other two variants (rs4714156 and rs9357271 of the BTBD9 gene) and the TS phenotype (P > 0.05) ( Table 1) . A significant difference in the allele distribution of rs9296249 between patients with TS and controls was also observed after Bonferroni correction (total TS vs. controls, P = 0.030; male TS vs. male control, P = 0.030). Haplotype analysis of single nucleotide polymorphisms in the BTBD9 gene showed that haplotype (rs4714156-rs9296249-rs9357271) TTC was significantly higher for the TS group (w 2 = 11.175, P = 0.001), whereas haplotype TCC was significantly lower for the control group (w 2 = 8.173, P = 0.004). Given that the HTR2C gene is located on the X chromosome, rs518147 and rs3813929 were assessed in a sex-specific manner and no significant difference was found between TS and controls (P > 0.05) ( Table 1) .
Discussion
The genetic contribution to the pathogenesis of TS is well established. Chromosome abnormalities on 3q, 7q31, 7q35-36.2, 8q22.1, 9p, 9q, 13q31, 15q13-q22.3, 16q, 17q25, and 18q22 have been found to be associated with the TS phenotype (Jankovic and Deng, 2007) , and linkage analysis also suggests that several regions on human chromosomes are associated with TS phenotype (Simonic et al., 1998; Barr et al., 1999 (Rivière et al., 2009; Dehning et al., 2010) , which may improve our understanding of the complex pathogenic mechanism of TS. The BTBD9 gene is mapped to chromosome 6p21.The gene encodes a 642-amino acid protein, which is widely expressed in the brain, such as the amygdala, cerebellum, hippocampus, caudate, and subthalamic nuclei, and in other organs, such as the heart, kidneys, pancreas, and liver. The BTBD9 protein is not well characterized, and its function remains unknown. The BTBD9 protein contains a BTB domain, also called POZ, which is known to be a protein-protein interaction motif. The functions of BTB (POZ) proteins include transcription repression, cytoskeleton regulation, tetramerization, gating of ion channels, as well as ubiquitin-dependent protein degradation (Stogios et al., 2005) . The molecular nature of this protein and the universal occurrence of the particular domains of BTBD9 make an assignment of a specific function difficult at present. A possible BTBD9 and HTR2C variants in TS Guo et al. 301 association between variations in the BTBD9 gene and restless legs syndrome, including rs9296249 and rs9357271, was evident in different populations of patients with restless legs syndrome (Stefansson et al., 2007; Winkelmann et al., 2007; Kemlink et al., 2009; Schimmelmann et al., 2009 ). The HTR2C gene was located on the Xq42. In our population sample, there was a three-fold excess of affected male patients, commensurate with a higher vulnerability for male individuals for developing TS. Compounds blocking dopamine receptors have been used successfully in the treatment of TS, and the HTR2C has an inhibitory effect on dopamine release (Robertson and Stern, 2000; Alex and Pehek, 2007) . Given the ethnic diversity in different populations, we therefore investigated the BTBD9 variants (rs4714156, rs9296249, and rs9357271) and the HTR2C variants (rs518147 and rs3813929) in our wellcharacterized cohort of 110 Chinese Han patients with TS and 440 normal controls from Mainland China. To our knowledge, this is the first study to assess the role of the BTBD9 and HTR2C gene variants in a cohort of Chinese TS patients. A statistically significant association was found between TS and rs9296249 (P = 0.030), consistent with previous findings (Rivière et al., 2009) , whereas for other variants, including rs4714156, rs9357271, rs518147, and rs3813929, no significant differences were found in gene frequencies (P > 0.05) between the disease and the control cohort, inconsistent with previous findings (Rivière et al., 2009; Dehning et al., 2010) . Interestingly, the C allele of rs9296249 and rs9357271 is the minor allele in a French Canadian population, whereas it is the major allele of these two variants in our Chinese Han population, suggesting ethnic differences. Given that our results are inconsistent with the previous findings (Rivière et al., 2009; Dehning et al., 2010) , these intronic variants (rs4714156, rs9357271, rs518147, and rs3813929) are likely not functional mutations but are variants in linkage disequilibrium with a nearby functional locus (Merette et al., 2000; Vilariño-Güell et al., 2010) . Although the variant rs9296249 does not represent a monogenic cause of TS, it does appear to confer an increased risk for the disease. The variant may be involved in the regulation of gene expression or may affect the transcription factor binding, native splicing, or other mechanisms that result in TS phenotypes (Thi Tran et al., 2005; Komar, 2007) . Larger-scale studies are warranted to document the conclusive evidence of the effect of the BTBD9 gene variant rs9296249 on the risk of TS. In addition, the genetic and epigenetic architecture of the BTBD9 gene and the neighboring genes should be studied further, which may shed new light on the pathogenic mechanism of TS. 
